Ketamine activated glutamatergic neurotransmission by GABAergic disinhibition in the medial prefrontal cortex

Neuropharmacology. 2021 Aug 15:194:108382. doi: 10.1016/j.neuropharm.2020.108382. Epub 2020 Nov 2.

Abstract

The fast-onset antidepressant actions of ketamine at subanaesthetic doses have attracted enormous interest in psychiatric disease treatment. However, the severe psychotomimetic side effects foster an urgent need to deeply understand the fast-onset antidepressant mechanism of ketamine. Ketamine, as a non-competitive NMDAR antagonist, increases the overall excitability of the mPFC, which is presumed to be essential for the antidepressant action of ketamine. However, the underlying mechanism is still elusive. Here, our results showed that low concentration of ketamine increased the activity and the excitatory/inhibitory ratio of pyramidal neurons; these changes were accompanied by diminished interneurons activity in the mPFC. Moreover, ketamine induced increases in excitatory transmission and antidepressant-like effects, which might rely on the functional intact of GABAergic system in the mPFC. These results suggest a critical role of the mPFC GABAergic system in the fast antidepressant effects of a subanaesthetic dose ketamine.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Action Potentials / drug effects
  • Animals
  • Antidepressive Agents / pharmacology*
  • GABAergic Neurons / drug effects*
  • GABAergic Neurons / physiology*
  • Hindlimb Suspension
  • Interneurons / drug effects
  • Ketamine / pharmacology*
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Open Field Test
  • Prefrontal Cortex / drug effects*
  • Prefrontal Cortex / physiology*
  • Pyramidal Cells / physiology
  • Receptors, N-Methyl-D-Aspartate / metabolism
  • Swimming
  • Synaptic Transmission / drug effects*

Substances

  • Antidepressive Agents
  • Receptors, N-Methyl-D-Aspartate
  • Ketamine